Spyre Therapeutics, Inc. (SYRE)

85.69 -1.40 (-1.61%) USD  |  NASDAQ  |  Sep 25, 16:00
85.70 +0.02 (+0.02%) After-Hours: 19:59
More

Spyre Therapeutics Cash and Short Term Investments (Annual) : 756.53M for Dec. 31, 2025

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for SYRE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2014. Start Trial.
Date Value
December 31, 2025 756.53M
December 31, 2024 603.09M
December 31, 2023 339.28M
December 31, 2022 55.71M
December 31, 2021 93.13M
December 31, 2020 146.27M
Date Value
December 31, 2019 71.95M
December 31, 2018 74.51M
December 31, 2017 50.30M
December 31, 2016 63.50M
December 31, 2015 33.14M
December 31, 2014 2.656M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
AbbVie, Inc. 5.257B
Incyte Corp. 3.581B
SELLAS Life Sciences Group, Inc. 71.89M
Relay Therapeutics, Inc. 554.52M
ACADIA Pharmaceuticals, Inc. 819.69M